4
Changes in Ownership
Ascendis Pharma A/S Filed Acc 0001610717-26-000176
EVP & Chief Financial Officer bought 250 shares at $223.32 ($55,830)
From the SEC's structured data for this filing
Trades in this filing
SMITH SCOTT THOMAS · EVP & Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-29 | Purchase : show line 1 in the form | +250 | $223.32 | $55,830 | 4,267 | D |
| Open-market purchases · 250 sh · avg $223.32 · $55,830 | ||||||
Loading xslF345X06/form4.xml…